| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ptc Therapeutics, Inc. (PTCT) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. PTCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 394.1K | $31.90M | - | |
| CFO | 90.3K | $7.31M | - | |
| Other | 80.1K | $6.49M | - | |
| VP | 79.1K | $6.41M | - | |
| Other | 72.7K | $5.89M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 646 | $27.25 | $17,604.02 | -1.0% | +21.0% | +70.3% | |
| Jan 30, 2024 | Boulding Mark Elliott55 | Exec. VP And CLO | Sell | 794 | $27.25 | $21,637.14 | -1.1% | +21.0% | +70.3% | |
| Jan 30, 2024 | Pauwels Eric62 | Chief Business Officer | Sell | 366 | $27.25 | $9,973.79 | -0.8% | +21.0% | +70.3% | |
| Jan 30, 2024 | Utter Christine Marie58 | SVP, Chief Accounting Officer | Sell | 318 | $27.25 | $8,665.75 | -0.9% | +21.0% | +70.3% | |
| Jan 22, 2024 | Jacobson Allan Steven51 | Director | Sale+OE | 10,000 | $27.38 | $273,804.00 | -44.7% | -4.8% | +65.9% | |
| Jan 9, 2024 | Boulding Mark Elliott55 | Exec. VP And CLO | Sell | 3,395 | $28.85 | $97,959.60 | -2.3% | -6.4% | +56.9% | |
| Jan 9, 2024 | Almstead Neil Gregory52 | Chief Technical Ops Officer | Sell | 2,910 | $28.85 | $83,950.34 | -2.1% | -6.4% | +56.9% | |
| Jan 9, 2024 | Utter Christine Marie58 | SVP, Finance &CAO | Sell | 2,841 | $28.86 | $81,986.14 | -3.7% | -6.4% | +56.9% | |
| Jan 9, 2024 | Pauwels Eric62 | Chief Business Officer | Sell | 3,634 | $28.85 | $104,852.19 | -3.8% | -6.4% | +56.9% | |
| Jan 9, 2024 | Klein Matthew B.55 | Chief Executive Officer | Sell | 7,680 | $28.91 | $221,995.91 | -2.3% | -6.4% | +56.9% |